Based on these results, we suggest that the CD26 level is a potential marker for predicting the invasive ability of NSCLC cells and the prognosis of lung cancer patients, and CD26 may regulate invasion of cells through EMT induction. Here, DPP4 is linked to non-small cell lung carcinoma.